Ausun Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 207 million yuan, a year-on-year decrease of 9.59%

According to the Zhitong Finance APP, Ausun Pharm disclosed its third-quarter report for 2025. The company achieved revenue of 646 million yuan in the first three quarters, a year-on-year decrease of 6.40%; net profit attributable to the parent company was 207 million yuan, a year-on-year decrease of 9.59%; net profit excluding non-recurring gains and losses was 183 million yuan, a year-on-year decrease of 13.83%; basic earnings per share were 0.25 yuan